Advertisement

Topics

ACM acquires ABS to accelerate growth driven by clinical trials, toxicology

11:55 EDT 20 Jun 2018 | Outsourcing-Pharma

ACM Global Laboratories has acquired ABS Laboratories to better serve its clients in the clinical trial market with an expanded "scientific acumen," says company president.

Original Article: ACM acquires ABS to accelerate growth driven by clinical trials, toxicology

NEXT ARTICLE

More From BioPortfolio on "ACM acquires ABS to accelerate growth driven by clinical trials, toxicology"

Advertisement
Quick Search
Advertisement
Advertisement